MB, BS, MD, FRCP, FESC: Senior Interventional Cardiologist Consultant in Oxford, UK

Professor Banning began working as a Senior Registrar at the John Radcliffe University Hospital in 1995.

He was appointed Consultant Cardiologist in 1999. He then became the Clinical Lead for cardiac medicine and in 2010 was appointed Divisional Director.

Professor Banning, is now the Senior Interventional Cardiologist in Oxford, UK. Working as a Consultant in interventional and general cardiology and is one of the founding members of the Oxford Private Heart and Lung Centre at Nuffield Health Oxford at The Manor Hospital.

Pioneering minimally invasive techniques

Professor Banning’s responsibilities as Consultant Cardiologist, both as an NHS consultant and in his private practice, cover a wide range of coronary conditions and procedures. He has championed the use of coronary stents as an alternative to coronary bypass and has been a leading investigator in most of the practice changing trials- Syntax, Excel, Syntax 2 , Noble.

His work on transcutaneous aortic valve implants (TAVI) using the Lotus valve has enabled many people to receive life changing heart valve replacements who could not otherwise undergo traditional open heart surgery due to frailness or ill-health.

Adrian Banning Cardiologist Oxford

Promoting heart health and an international reputation for cardiology

He has also provided expert advice to a much wider audience in his position as Boots the Chemist’s Health Club cardiology expert.

Professor Banning’s calm approach to cardiology, rapport with patients and growing international reputation secured his spot in the top 10.

In 2010, Professor Banning was featured in the Daily Mail’s top 10 list of cardiologists. To compile the results, they asked 40 of the UK’s cardiologists to recommend five people they would trust to treat their family or close friends.

Adrian Banning Cardiologist Oxford

Key representative roles:

  • 2023: Course Co-director TCT Asia Pacific- Seoul Korea (TCTAP)
  • 2023: Founding member European cardiovascular research foundation (ECRI), Rotterdam
  • 2023: Chair of research Committee European cardiovascular research institute (ECRI)
  • 2020: Recognised as World expert (top 50 cited authors) in Coronary stents by Expertscape
  • 2020: Recognised as World expert (top 50 cited authors) in Endovascular procedures by Expertscape
  • 2019: TCT Global partner
  • 2019: EuroPCR Programme Committee
  • 2012-18: Cardiovascular Research Foundation (TCT) programmes group
  • 2017-18: EAPCI / SCTS Joint Guideline Committee on Revascularisation
  • 2016-20: Member of 2018-2020 EAPCI National Cardiac Societies & International Affairs Committee
  • 2015: Board member European Bifurcation Club
  • 2017-19: Elected member EAPCI nominating Committee
  • 2020-2021: BCS/BCIS/SCTS/ACTACC Advisory working group on MDTs
  • 2019-2021: Chairman Advisory Group on NHS England Heart attack Pathway
  • 2019: National Clinical Advisor, NHS England TAVI and aortic valve disease Specialised Cardiac Improvement programme
  • 2018-2021: Chair NHS England Cardiac Improvement Programme Aortic valve disease working group
  • 2018: Chair NHS England HCTED – TAVI devices working group and Structural cardiac devices
  • 2017-18: NHS Innovation and Technology assessment panel
  • 2015-19: British Cardiac Society Council and Executive
  • 2015–20: President British Cardiac Intervention Society
  • 2015–6: Secretary British Cardiac Intervention Society
  • 2013 – 15: Chairman National Clinical Standards Group, British Cardiac Intervention Society
  • 2012 – 20: Data Monitoring and Action Group (DMAG) for British Cardiac Intervention Society.
  • 2009 – 19: British Cardiac Intervention Society Programme Committee
  • 2008 – 12: British Cardiac Intervention Society Research Committee
  • 2009 – 12: European Association of Percutaneous Intervention Fellowship Committee
  • 2009 – 11: Atherothrombosis and Hypertension National Clinical Study Group
  • 2008 – 11: South Central Cardiac CRN representative
  • 2002 – 6: Lead Clinician Thames Valley Cardiac Network
  • 2003 – 7: Elected Council Member British Cardiac Intervention Society
  • 1997: British Cardiac Society Working Group ‘Ageism in Cardiology’

Videos

Case 1:

Watch Professor Banning undertake PCI in a patient with multivessel coronary disease as part of the Syntax 2 trail.

Case 2:

In this video Professor Banning undertakes rotablation and PCI in a patient with a heavily calcified coronary artery.

Case 3:

Professor Banning undertakes PCI in a patient with a very tortuous chronically occluded right coronary artery.

Teaching

Training, teaching and graduate supervision are core parts of Professor Banning’s work, helping to educate others in his pioneering work and to promote best practice cardiology techniques worldwide. In Oxford, Professor Banning and his colleagues have held many ‘Oxford Live’ coronary courses. Over 250 delegates attend the course, making it the largest independent live course in the UK.

In 2010 Oxford was selected by the Cardiovascular Research Foundation, New York, as one of 18 worldwide live case sites. Professor Banning was Site Principle and Oxford transmitted four live cases. In 2014 he hosted live case presentations from Oxford for the PCR course in Paris. Live stent procedures performed by Professor Banning were transmitted from Oxford to audiences of over 5000 cardiologists.

Farther afield, Professor Banning regularly attends intervention training courses as live case operator and lecturer, including regular appearances at the ‘Meet the Masters’ series in Paris – a Europe-wide training programme in PCI – and American Transcatheter Therapeutics (TCT) meetings. Professor Banning is frequently invited to lecture in his field. Over the years, he’s given many lectures, a selection of which follows:

Adrian Banning Cardiologist Oxford
  • The future of drug eluting stents, PCR Paris, 2010
  • Follow-on PCI – A chancers charter?, BCS Manchester, 2010
  • PCI in diabetics: What are the indications?, TCT San Francisco, 2009
  • Syntax intervention for left main stenosis, BCR Barcelona, 2009
  • Left main PCI current indications, European Society of Cardiology, 2009
  • The role of FFR in ACS. Seoul South Korea 2015
  • PCI v surgery : the debate continues Melbourne Australia 2015

He is also educational supervisor to research fellows at home and abroad. Several of his fellows have won research awards for their work.

Professor Banning’s research interests are covered in detail on the research page here.